Shikimax

Biotechnology netherlands

SHIKIMAX addresses the critical need for sustainability in the chemical industry, particularly in the production of aromatic compounds found in everyday products, from food additives to polymers. Traditional production methods of aromatics rely heavily on fossil fuels, resulting in substantial greenhouse gas emissions and environmental degradation. In response, we harness advanced metabolic engineering to develop […]

Super Mendelian Microfactories

Biotechnology netherlands

Yeast has been used for centuries to make bread, beer, and wine. Since the late 20th century, it has also been used to produce important medicines like insulin. For the bioeconomy, where biological processes create sustainable products, yeast can be harnessed to make a wide range of products, from flavours and fragrances to materials and […]

NICy

Biotechnology netherlands

Plants produce a highly diverse scala of natural molecules that have significant value in products used in daily life. These molecules, including aromatics, terpenoids, cannabinoids, and lipophilic molecules, are high value products and are currently extracted from plants or are chemically synthesized. Both methods negatively affect the environment, thus we need cost-effective, sustainable alternative production […]

Evoducta

Biotechnology netherlands

Many everyday products are produced through fermentation by microorganisms—some obvious, like the yoghurt you have for breakfast; others less obvious, like the citric acid in your favourite soda. The long list of industrial fermentation processes continues to grow for two key reasons: (1) They can produce complex substances that are otherwise difficult or impossible to […]

Iprotics

biotechnology netherlands

iProtics is developing a novel drug to treat blood cancers and autoimmune diseases more effectively and with fewer side effects than current treatments. Existing drugs inhibit both immunoproteasomes and constitutive proteasomes, causing severe side effects by damaging healthy cells. iProtics has created a first-in-class drug that selectively inhibits only immunoproteasomes, which are primarily found in […]